Advertisement
Screener

GINKGO BIOWORKS HOLDINGS, INC. (DNA) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid

1.6 / 5 stars · 16/49 Roast Me

GINKGO BIOWORKS HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid

GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid of $9.80 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-25.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid · last filed 2025-02-25

  • GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, share-based liabilities paid for fiscal 2022 was $9.80M.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid 12 month
2022-12-31$9.80M
10-K · filed 2025-02-25